| Transactions | |||
| All | Buy | Sell | Option Exercise |
Filer's Name |
Relationship/ Title |
Trans. Date |
Trans. Type |
Ownership Type |
Security Type |
Shares |
Price |
Trans. Value |
Total Shares Owned |
| Behbahani Ali | Director | 03/20/2026 | AA | Direct | COM | 6,919 | $2.15 | $14,875.85 | 93,568 |
| Raman Prakash | Director | 03/20/2026 | AA | Direct | COM | 6,105 | $2.15 | $13,125.75 | 37,132 |
| Behbahani Ali | Director | 12/12/2025 | AA | Direct | COM | 5,208 | $2.76 | $14,374.08 | 86,649 |
| Raman Prakash | Director | 12/12/2025 | AA | Direct | COM | 4,665 | $2.76 | $12,875.40 | 31,027 |
| Behbahani Ali | Director | 09/19/2025 | AA | Direct | COM | 4,291 | $3.35 | $14,374.85 | 81,441 |
| Raman Prakash | Director | 09/19/2025 | AA | Direct | COM | 3,843 | $3.35 | $12,874.05 | 26,362 |
| Behbahani Ali | Director | 06/20/2025 | AA | Direct | COM | 6,170 | $2.33 | $14,376.10 | 77,150 |
| Raman Prakash | Director | 06/20/2025 | AA | Direct | COM | 5,526 | $2.33 | $12,875.58 | 22,519 |
| Behbahani Ali | Director | 03/21/2025 | AA | Direct | COM | 7,646 | $1.88 | $14,374.48 | 70,980 |
| Raman Prakash | Director | 03/21/2025 | AA | Direct | COM | 6,848 | $1.88 | $12,874.24 | 16,993 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 500,000 | $2.12 | $1,058,450.00 | 2,733,547 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 584,292 | $1.95 | $1,141,239.13 | 3,233,547 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 400,000 | $2.09 | $837,160.00 | 3,817,839 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 2,000,000 | $2.00 | $4,000,800.00 | 4,217,839 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 1,000,000 | $2.31 | $2,308,100.00 | 6,217,839 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 300,000 | $1.94 | $582,900.00 | 7,217,839 |
| Biotech Growth N V | Other | 03/19/2025 | DS | Direct | COM | 1,000,000 | $2.07 | $2,069,100.00 | 7,517,839 |
| Hatzis-Schoch Brent | SEE REMARKS | 01/30/2025 | AA | Direct | COM | 75,000 | $0.00 | $0.00 | 83,400 |
| Jones Erika | SEE REMARKS | 01/30/2025 | AA | Direct | COM | 75,000 | $0.00 | $0.00 | 85,150 |
| Buck Elizabeth | CHIEF SCIENTIFIC OFFICER | 01/30/2025 | AA | Direct | COM | 75,000 | $0.00 | $0.00 | 170,192 |
| Yurasov Sergey | CHIEF MEDICAL OFFICER | 01/30/2025 | AA | Direct | COM | 75,000 | $0.00 | $0.00 | 75,000 |
| Velleca Mark A. | PRESIDENT & CEO | 01/30/2025 | AA | Direct | COM | 75,000 | $0.00 | $0.00 | 121,522 |
| Behbahani Ali | Director | 12/13/2024 | AA | Direct | COM | 5,750 | $2.50 | $14,375.00 | 63,334 |
| Campbell Shannon | Director | 12/13/2024 | AA | Direct | COM | 4,500 | $2.50 | $11,250.00 | 8,865 |
| Raman Prakash | Director | 12/13/2024 | AA | Direct | COM | 5,150 | $2.50 | $12,875.00 | 10,145 |
| 1   2  Next Last  You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
![]() |
Send to Excel | |||||||